STOCK TITAN

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Amgen (NASDAQ:AMGN) will report Q3 2025 financial results on Tuesday, November 4, 2025 after U.S. market close, followed by a conference call at 4:30 p.m. ET.

Amgen CEO Robert A. Bradway and senior management will participate. Live audio will be webcast and available to media, investors, and the public on Amgen's Investor Relations Events Calendar at www.amgen.com. Webcast links and presentation times are listed on the events calendar. The webcast will be archived and available for replay for at least 90 days after the event.

Amgen (NASDAQ:AMGN) riporterà i risultati finanziari del Q3 2025 nel 4 novembre 2025, martedì dopo la chiusura del mercato statunitense, seguito da una conferenza telefonica alle 16:30 ET.

Il CEO di Amgen Robert A. Bradway e i membri della direzione senior parteciperanno. L'audio in diretta sarà trasmesso in webcast e disponibile per i media, gli investitori e il pubblico sul calendario degli eventi della Relazioni con gli Investitori di Amgen all'indirizzo www.amgen.com. I link del webcast e gli orari delle presentazioni sono elencati nel calendario degli eventi. Il webcast sarà archiviato e disponibile per la riproduzione per almeno 90 giorni dopo l'evento.

Amgen (NASDAQ:AMGN) reportará los resultados financieros de Q3 2025 el martes 4 de noviembre de 2025 después del cierre del mercado de EE. UU., seguido de una llamada de conferencia a las 4:30 p.m. ET.

El CEO de Amgen, Robert A. Bradway, y la alta dirección participarán. El audio en vivo se transmitirá por webcast y estará disponible para medios, inversores y público en el Calendario de Eventos de Relaciones con Inversionistas de Amgen en www.amgen.com. Los enlaces del webcast y los horarios de las presentaciones se encuentran en el calendario de eventos. El webcast quedará archivado y disponible para reproducción durante al menos 90 días después del evento.

Amgen (NASDAQ:AMGN)Q3 2025 재무 실적을 미국 시장 폐장 이후 2025년 11월 4일 화요일에 발표하고, 이후 동부 표준시 기준 오후 4:30에 컨퍼런스 콜이 진행됩니다.

Amgen의 CEO Robert A. Bradway 및 고위 경영진이 참여합니다. 라이브 오디오는 Amgen의 IR 이벤트 캘린더 www.amgen.com에서 미디어, 투자자 및 일반 대중에게 webcast로 제공됩니다. 웹캐스트 링크와 발표 시간은 이벤트 캘린더에 목록으로 표시됩니다. 웹캐스트는 이벤트 후 최소 90일간 보관되어 재생할 수 있습니다.

Amgen (NASDAQ:AMGN) publiera les résultats financiers du T3 2025 le Mardi 4 novembre 2025 après la fermeture des marchés américains, suivi d'une conférence téléphonique à 16 h 30 HE.

Le PDG d'Amgen, Robert A. Bradway, et la direction supérieure participeront. L'audio en direct sera diffusé en webcast et accessible aux médias, investisseurs et au grand public sur le calendrier des événements des Relations avec les Investisseurs d'Amgen à l'adresse www.amgen.com. Les liens du webcast et les horaires des présentations sont indiqués sur le calendrier des événements. Le webcast sera archivé et disponible en rediffusion pendant au moins 90 jours après l'événement.

Amgen (NASDAQ:AMGN) wird die finanziellen Ergebnisse für Q3 2025 am Dienstag, 4. November 2025 nach Börsenschluss in den USA berichten, gefolgt von einer Konferenzschaltung um 16:30 Uhr ET.

Der Amgen-CEO Robert A. Bradway und das Senior-Management werden teilnehmen. Live-Audio wird gestreamt und steht Medien, Anlegern und der Öffentlichkeit im Investor Relations Events Calendar von Amgen unter www.amgen.com zur Verfügung. Die Webcast-Links und Präsentationszeiten sind im Veranstaltungs Kalendereintrag aufgeführt. Der Webcast wird archiviert und mindestens 90 Tage nach der Veranstaltung wiedergegeben.

Amgen (NASDAQ:AMGN) ستعلن عن نتائجها المالية للربع الثالث 2025 في يوم الثلاثاء 4 نوفمبر 2025 بعد إغلاق السوق الأمريكية، تليها مكالمة مؤتمرات الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة.

سيشارك Robert A. Bradway الرئيس التنفيذي لشركة أمجين وكبار المديرين. ستكون الصوتيات المباشرة متاحة عبر بث مباشر للميديا والمستثمرين والجمهور على تقويم فعاليات علاقات المستثمرين في أمجين على www.amgen.com. روابط البث وأوقات العروض مذكورة في تقويم الفعاليات. سيتم أرشفة البث وسيكون متاحاً لإعادة المشاهدة لمدة لا تقل عن 90 يوماً بعد الحدث.

Amgen (NASDAQ:AMGN) 将在美国市场收盘后于2025年11月4日,星期二公布2025年第三季度财务业绩,随后举行时间为东部时间下午4:30的电话会议。

Amgen首席执行官Robert A. Bradway及高级管理层将参加。现场音频将通过 webcast 向媒体、投资者及公众在 Amgen 的投资者关系活动日历 www.amgen.com 上播出。 webcast 链接及演示时间在活动日历中列出。 webcast 将被存档,活动结束后至少可回放90 天

Positive
  • None.
Negative
  • None.

THOUSAND OAKS, Calif., Oct. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2025 financial results on Tuesday, November 4, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube and Threads

CONTACT: Amgen, Thousand Oaks 
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2025-third-quarter-financial-results-302598855.html

SOURCE Amgen

FAQ

When will Amgen (AMGN) report its Q3 2025 results?

Amgen will report Q3 2025 results on Tuesday, November 4, 2025 after the U.S. market close.

What time is the Amgen (AMGN) Q3 2025 conference call and webcast?

The conference call and live webcast are scheduled for 4:30 p.m. ET on November 4, 2025.

Who will speak on Amgen's (AMGN) Q3 2025 earnings call?

Amgen CEO Robert A. Bradway and other members of senior management will participate.

Where can I find the Amgen (AMGN) Q3 2025 webcast link and presentation times?

Webcast links and presentation times are posted on Amgen's Investor Relations Events Calendar at www.amgen.com under Investors.

Will the Amgen (AMGN) Q3 2025 webcast be available after the live event?

Yes. The webcast will be archived and available for replay for at least 90 days after the event.

Can members of the media and the public access Amgen's (AMGN) Q3 2025 webcast?

Yes. Live audio will be simultaneously broadcast over the internet and available to media, investors, and the general public.
Amgen Inc

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Latest SEC Filings

AMGN Stock Data

157.25B
537.17M
0.21%
84.13%
2.19%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
THOUSAND OAKS